A1–7 or GABA monotherapy reduced the area under the blood glucose curve of glucose tolerance test and insulin tolerance test, alleviated HFD-induced hyperinsulinemia, and thus improved glucose tolerance and insulin sensitivity (Figs. 1, I–L and S1C). Here, INS is linked to Hyperinsulinemia.